4.5 Article

LINEAGE-SPECIFIC VARIATION IN SLOW- AND FAST-X EVOLUTION IN PRIMATES

Journal

EVOLUTION
Volume 66, Issue 6, Pages 1751-1761

Publisher

WILEY
DOI: 10.1111/j.1558-5646.2011.01556.x

Keywords

Male mutation bias; effective population size; mating system; life history traits; adaptive evolution

Ask authors/readers for more resources

Theories predict that the evolutionary rates of X-linked regions can differ from those of autosomal regions. The male-biased mutation theory predicts a slower rate of neutral substitution on the X chromosome (slow-X evolution), as the X spends less time in male germlines, where more mutations originate per generation than in female germlines. The fast-X theory, however, predicts a faster rate of adaptive substitution on the X chromosome when newly arising beneficial mutations are, on average, partially recessive (fast-X evolution), as the X enjoys a greater efficacy of positive selection. The slow- and fast-X processes are expected to interact as the degree of male-biased mutation can in turn influence the relative rate of adaptive evolution on the X. Here, we investigate lineage-specific variation in, and the interaction of, slow- and fast-X processes using genomic data from four primates. We find consistent evidence for slow-X evolution in all lineages. In contrast, evidence for fast-X evolution exists in only a subset of lineages. In particular, the marmoset lineage, which shows the strongest evidence of fast-X, exhibits the lowest male mutation bias. We discuss the possible interaction between slow- and fast-X evolution and other factors that influence the degrees of slow- and fast-X evolution.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Genomic and Network Patterns of Schizophrenia Genetic Variation in Human Evolutionary Accelerated Regions

Ke Xu, Eric E. Schadt, Katherine S. Pollard, Panos Roussos, Joel T. Dudley

MOLECULAR BIOLOGY AND EVOLUTION (2015)

Article Biochemistry & Molecular Biology

The tempo and mode of New World monkey evolution and biogeography in the context of phylogenomic analysis

Natalie M. Jameson Kiesling, Soojin V. Yi, Ke Xu, F. Gianluca Sperone, Derek E. Wildman

MOLECULAR PHYLOGENETICS AND EVOLUTION (2015)

Article Psychiatry

Deciphering H3K4me3 broad domains associated with gene-regulatory networks and conserved epigenomic landscapes in the human brain

A. Dincer, D. P. Gavin, K. Xu, B. Zhang, J. T. Dudley, E. E. Schadt, S. Akbarian

TRANSLATIONAL PSYCHIATRY (2015)

Article Biochemistry & Molecular Biology

Open chromatin profiling of human postmortem brain infers functional roles for non-coding schizophrenia loci

John F. Fullard, Claudia Giambartolomei, Mads E. Hauberg, Ke Xu, Georgios Voloudakis, Zhiping Shao, Christopher Bare, Joel T. Dudley, Manuel Mattheisen, Nikolaos K. Robakis, Vahram Haroutunian, Panos Roussos

HUMAN MOLECULAR GENETICS (2017)

Correction Biochemistry & Molecular Biology

Open chromatin profiling of human postmortem brain infers functional roles for non-coding schizophrenia loci (vol 26, pg 1942, 2017)

John F. Fullard, Claudia Giambartolomei, Mads E. Hauberg, Ke Xu, Georgios Voloudakis, Zhiping Shao, Christopher Bare, Joel T. Dudley, Manuel Mattheisen, Nikolaos K. Robakis, Vahram Haroutunian, Panos Roussos

HUMAN MOLECULAR GENETICS (2020)

Article Biochemistry & Molecular Biology

Adaptive Landscape of Protein Variation in Human Exomes

Ravi Patel, Laura B. Scheinfeldt, Maxwell D. Sanderford, Tamera R. Lanham, Koichiro Tamura, Alexander Platt, Benjamin S. Glicksberg, Ke Xu, Joel T. Dudley, Sudhir Kumar

MOLECULAR BIOLOGY AND EVOLUTION (2018)

Article Clinical Neurology

Structure and evolution of double minutes in diagnosis and relapse brain tumors

Ke Xu, Liang Ding, Ti-Cheng Chang, Ying Shao, Jason Chiang, Heather Mulder, Shuoguo Wang, Tim I. Shaw, Ji Wen, Laura Hover, Clay McLeod, Yong-Dong Wang, John Easton, Michael Rusch, James Dalton, James R. Downing, David W. Ellison, Jinghui Zhang, Suzanne J. Baker, Gang Wu

ACTA NEUROPATHOLOGICA (2019)

Article Biochemistry & Molecular Biology

The evolution of lineage-specific clusters of single nucleotide substitutions in the human genome

Ke Xu, Jianrong Wang, Navin Elango, Soojin V. Yi

MOLECULAR PHYLOGENETICS AND EVOLUTION (2013)

Article Genetics & Heredity

Genome-wide analysis indicates association between heterozygote advantage and healthy aging in humans

Ke Xu, Roman Kosoy, Khader Shameer, Sudhir Kumar, Li Liu, Ben Readhead, Gillian M. Belbin, Hao-Chih Lee, Rong Chen, Joel T. Dudley

BMC GENETICS (2019)

Article Hematology

Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia

Benshang Li, Samuel W. Brady, Xiaotu Ma, Shuhong Shen, Yingchi Zhang, Yongjin Li, Karol Szlachta, Li Dong, Yu Liu, Fan Yang, Ningling Wang, Diane A. Flasch, Matthew A. Myers, Heather L. Mulder, Lixia Ding, Yanling Liu, Liqing Tian, Kohei Hagiwara, Ke Xu, Xin Zhou, Edgar Sioson, Tianyi Wang, Liu Yang, Jie Zhao, Hui Zhang, Ying Shao, Hongye Sun, Lele Sun, Jiaoyang Cai, Hui-Ying Sun, Ting-Nien Lin, Lijuan Du, Hui Li, Michael Rusch, Michael N. Edmonson, John Easton, Xiaofan Zhu, Jingliao Zhang, Cheng Cheng, Benjamin J. Raphael, Jingyan Tang, James R. Downing, Ludmil B. Alexandrov, Bin-Bing S. Zhou, Ching-Hon Pui, Jun J. Yang, Jinghui Zhang

BLOOD (2020)

Article Clinical Neurology

Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource

Kyle S. Smith, Ke Xu, Kimberly S. Mercer, Frederick Boop, Paul Klimo, Michael DeCupyere, Jose Grenet, Sarah Robinson, Paige Dunphy, Suzanne J. Baker, David W. Ellison, Thomas E. Merchant, Santhosh A. Upadayaya, Amar Gajjar, Gang Wu, Brent A. Orr, Giles W. Robinson, Paul A. Northcott, Martine F. Roussel

ACTA NEUROPATHOLOGICA (2020)

Article Multidisciplinary Sciences

Comprehensive molecular characterization of pediatric radiation-induced high-grade glioma

John DeSisto, John T. Lucas, Ke Xu, Andrew Donson, Tong Lin, Bridget Sanford, Gang Wu, Quynh T. Tran, Dale Hedges, Chih-Yang Hsu, Gregory T. Armstrong, Michael Arnold, Smita Bhatia, Patrick Flannery, Rakeb Lemma, Lakotah Hardie, Ulrich Schueller, Sujatha Venkataraman, Lindsey M. Hoffman, Kathleen Dorris, Jean M. Mulcahy Levy, Todd C. Hankinson, Michael Handler, Arthur K. Liu, Nicholas Foreman, Rajeev Vibhakar, Kenneth Jones, Sariah Allen, Jinghui Zhang, Suzanne J. Baker, Thomas E. Merchant, Brent A. Orr, Adam L. Green

Summary: Radiation-induced high-grade gliomas (RIGs) are an incurable late complication of cranial radiation therapy. Genomic analysis revealed common copy-number alterations and different subgroups based on DNA methylation and transcriptome profiles, suggesting potential therapeutic targets such as microtubule inhibitors and MEK inhibitors. These findings provide insights into the molecular mechanisms of RIGs and potential treatment strategies.

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma

Chen He, Ke Xu, Xiaoyan Zhu, Paige S. Dunphy, Brian Gudenas, Wenwei Lin, Nathaniel Twarog, Laura D. Hover, Chang-Hyuk Kwon, Lawryn H. Kasper, Junyuan Zhang, Xiaoyu Li, James Dalton, Barbara Jonchere, Kimberly S. Mercer, Duane G. Currier, William Caufield, Yingzhe Wang, Jia Xie, Alberto Broniscer, Cynthia Wetmore, Santhosh A. Upadhyaya, Ibrahim Qaddoumi, Paul Klimo, Frederick Boop, Amar Gajjar, Jinghui Zhang, Brent A. Orr, Giles W. Robinson, Michelle Monje, Burgess B. Freeman, Martine F. Roussel, Paul A. Northcott, Taosheng Chen, Zoran Rankovic, Gang Wu, Jason Chiang, Christopher L. Tinkle, Anang A. Shelat, Suzanne J. Baker

Summary: In this study, researchers established a series of models related to pediatric high-grade gliomas, replicating the histopathology, DNA methylation signatures, and gene expression patterns of patient tumors. High-throughput screening results showed variable responses to PI3K/mTOR and MEK pathway inhibitors. These models provide a rich resource for pediatric brain tumor research.

NATURE COMMUNICATIONS (2021)

Article Oncology

Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma

Allison Pribnow, Barbara Jonchere, Jingjing Liu, Kyle S. Smith, Olivia Campagne, Ke Xu, Sarah Robinson, Yogesh Patel, Arzu Onar-Thomas, Gang Wu, Clinton F. Stewart, Paul A. Northcott, Jiyang Yu, Giles W. Robinson, Martine F. Roussel

Summary: Combining ribociclib and gemcitabine can effectively slow down tumor progression and metastasis, and improve survival in patients with G3MB. Molecular analysis reveals significant changes in gene activity and expression, which may be related to cell cycle progression, DNA damage response, and neuronal differentiation. This study suggests that the combination therapy of ribociclib and gemcitabine is a promising treatment strategy for children with G3MB and deserves further investigation.

MOLECULAR CANCER THERAPEUTICS (2022)

Article Oncology

Pathogenic Variants in Adult-Onset Cancer Predisposition Genes in Pediatric Cancer: Prevalence and Impact on Tumor Molecular Features and Clinical Management

Rose B. McGee, Ninad Oak, Lynn Harrison, Ke Xu, Regina Nuccio, Alise K. Blake, Roya Mostafavi, Sara Lewis, Leslie M. Taylor, Manish Kubal, Annastasia Ouma, Stacy J. Hines-Dowell, Cheng Cheng, Larissa V. Furtado, Kim E. Nichols

Summary: This study retrospectively examined the prevalence and impact of pathogenic variants in adult-onset cancer predisposition genes (aoCPGs) in pediatric tumors. They found that a small percentage of patients had tumors with aoCPG variants, with some of these variants being of germline origin. These variants were associated with alterations in tumor molecular profiles, but were not commonly used to change treatment decisions in pediatric cancers.

CLINICAL CANCER RESEARCH (2023)

No Data Available